Morphogen-IX

Read more
Nick Morrell's photo - Founder & CEO of Morphogen-IX

Founder & CEO

Nick Morrell

CEO Approval Rating

83/100

Founded

2015

Headquarters

Status

PrivateIndependent Company

Social Links

Est. Annual Revenue
$ < 1M
Agree?
Est. Employees
3
Agree?
Funding
$23.2M

Morphogen-IX Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

Morphogen-IX News

Morphogen-IX Press Releases

Morphogen-IX Headquarters

Babraham Research Campus Babraham,

Cambridge, EnglandCB22 3AT

Driving Directions »

Morphogen-IX Summary

ABOUT

Overview

Morphogen-IX is a drug discovery company that develops bone morphogenetic proteins for the treatment of pulmonary arterial hypertension. Morphogen-IX was founded in 2015. Morphogen-IX's headquarters is located in Cambridge, England, GB CB22 3AT. Morp...

CEO

Morphogen-IX's Founder & CEO, Nick Morrell, currently has an approval rating of 83%. Morphogen-IX's primary competitors are NovaBiotics, Nemesis Bioscience & Bicycle Therapeutics.

Acquisitions

There have been no acquisitions found related to Morphogen-IX

Investments

Recent investment data cannot be found related to Morphogen-IX

Frequently Asked Questions about Morphogen-IX

  1. When was Morphogen-IX founded?

    Morphogen-IX was founded in 2015
  2. Who is Morphogen-IX's CEO?

    Morphogen-IX's CEO is Nick Morrell
  3. How much revenue does Morphogen-IX generate?

    Morphogen-IX generates $ < 1M in revenue
  4. How much funding does Morphogen-IX have?

    Morphogen-IX has historically raised $23.2M in funding
  1. Where is Morphogen-IX's headquarters?

    Morphogen-IX's headquarters is in Cambridge England, GB
  2. How many employees does Morphogen-IX have?

    Morphogen-IX has 3 employees
  3. What sector does Morphogen-IX operate in?

    Morphogen-IX is in Biotechnology
  4. Who are Morphogen-IX's competitors?

    Morphogen-IX's top competitors are NovaBiotics, Nemesis Bioscience, Bicycle Therapeutics

Trending Companies